Fluridil: A Promising Topical Treatment for Hair Loss – What You Need to Know

Fluridil is a powerful topical anti-androgen that inhibits the effects of testosterone and DHT in the scalp, offering hope for regrowth without harmful side effects. But is it effective and safe? Join us as we delve into the world of Fluridil to discover its potential as a game-changing hair growth product.

How EUCAPIL® works - How EUCAPIL® works
Image courtesy of eucapil-shop.eu


Fluridil: A Revolutionary Treatment for Androgenetic Hair Loss (AGA) and Hirsutism

Developed as part of an innovative study, this unique compound can be applied locally without causing systemic side effects. While its patent expired in 2021, generic alternatives have yet to enter the market. Although it’s approved for cosmetic use in Europe, FDA or EMA approval for AGA treatment is still pending. You can purchase it online for $83.

How Does Fluridil Work?

Classified as a non-steroidal anti-androgen (NSAA), Fluridil disrupts the binding process between testosterone/DHT and their receptors. This disruption prevents hair follicle miniaturization and loss caused by these hormones. Although its exact mechanism remains mysterious, Fluridil’s unique ability to break down in aqueous solutions sets it apart from other NSAAs, reducing the risks of systemic side effects.

Clinical Data

Two clinical studies have explored Fluridil’s potential in treating AGA—one involving men and the other involving women.

  • In the men’s study, participants applied a 2% Fluridil solution topically for 9 months. The results indicated an initial increase in growing hairs and a decrease in non-growing hairs within the first 3 months, with no effects on testosterone levels or sexual function. However, the positive effects waned after 3 months, suggesting a plateau in efficacy.
  • The women’s study, conducted over 9 months, showed that Fluridil did not significantly increase the number of growing hairs or decrease non-growing hairs. Hair diameter improved at the 6-month and 9-month marks, but overall, the evidence was inconclusive due to small sample size and other confounding factors.

Is Fluridil the Solution for You?

For men experiencing hair loss, Fluridil offers a potential short-term solution. This innovative product is specifically designed to target the problem area without affecting the rest of your body. And here’s the best part: no serious adverse effects have been reported in studies conducted so far. However, it’s important to note that long-term safety remains uncertain due to the limited duration of these studies. While Fluridil may not be FDA or EMA approved, it could still be an option worth considering if you’re comfortable with using a product that has minimal safety and efficacy data. Women with AGA should approach Fluridil cautiously, especially if they’ve previously used anti-androgenic medications. Keep in mind that we don’t yet know its long-term effects or broader safety profiles – but isn’t it exciting to think about all the possibilities this groundbreaking treatment holds?


Fluridil holds potential as a breakthrough topical treatment for hair loss. However, it is crucial to note that there is currently limited scientific evidence confirming its effectiveness and safety. Therefore, before deciding whether to try Fluridil, it is essential for individuals to seek guidance from healthcare experts and thoughtfully evaluate the available data in light of the potential benefits. To truly understand Fluridil’s role in managing hair loss, further research and long-term studies are imperative.


Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg. 2002 Aug;28(8):678-85. doi: 10.1046/j.1524-4725.2002.02017.x. Erratum in: Dermatol Surg 2002 Oct;28(8):following 970. PMID: 12174057.


Solomon, K., Velders, G., Wilson, S., MAdronich, S., Longstreth, J., Aucamp, P., Bornman, J. (2016). Sources, Fates, Toxicity and Risks of Trifluoroacetic Acid and its Salts: Relevance to Substances Regulated Under the Montreal and Kyoto Protocols. Journal of Toxicology and Environmental Health. 43(15-16), 597-603. Available at: https://doi.org/10.1080/10937404.2016.1175981